Guberina, M <br/><br/>
Heart dose exposure as prognostic marker after radiotherapy for resectable stage IIIA/B non-small-cell lung cancer: secondary analysis of a randomized trial.  [electronic resource] 

 -  Annals of oncology : official journal of the European Society for Medical Oncology  05 2017 
 - 1084-1089 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1569-8041 
<br/><br/><label>Standard No.: </label>10.1093/annonc/mdx069  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Carcinoma, Non-Small-Cell Lung--mortality<br/>Chemoradiotherapy--adverse effects<br/>Dose-Response Relationship, Radiation<br/>Female<br/>Heart--radiation effects<br/>Humans<br/>Lung Neoplasms--mortality<br/>Male<br/>Middle Aged<br/>Myocardium--pathology<br/>Neoplasm Staging<br/>Prognosis<br/>Proportional Hazards Models<br/>Radiation Injuries--diagnosis<br/>Treatment Outcome